Results 221 to 230 of about 24,059,316 (329)
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source
A scoping review of models to identify transgender patients in electronic health records. [PDF]
Becker RA, Kolli JUL, Walsh CG.
europepmc +1 more source
Fitting Large Factor Analysis Models With Ordinal Data [PDF]
Christine DiStefano +4 more
openalex +1 more source
Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici +8 more
wiley +1 more source
Evaluation of trajectory analysis for disease risk assessment: a scoping review. [PDF]
Pollington F +5 more
europepmc +1 more source
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source
Training large language models on narrow tasks can lead to broad misalignment. [PDF]
Betley J +8 more
europepmc +1 more source
Model Validation and Model Error Modeling
To validate an estimated model and to have a good understanding of its reliability is a central aspect of System Identification. This contribution discusses these aspects in the light of model error models that are explicit descriptions of the model error.
openaire +1 more source
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source

